Ubs Group Ag Amneal Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,582,750 shares of AMRX stock, worth $16.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,582,750

Previous 1,812,375 12.67%

Holding current value

$16.6 Million

Previous $15.2 Million 15.69%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.97 - $8.23 $1.6 Million - $1.89 Million	-229,625 Reduced 12.67%	1,582,750 $12.8 Million
Q1 2025 May 13, 2025	BUY	$7.72 - $9.01 $1.13 Million - $1.32 Million	146,850 Added 8.82%	1,812,375 $15.2 Million
Q4 2024 Feb 14, 2025	SELL	$7.69 - $9.25 $155 Million - $186 Million	-20,107,524 Reduced 92.35%	1,665,525 $13.2 Million
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $490,963 - $675,265	-76,474 Reduced 0.35%	21,773,049 $181 Million
Q2 2024 Aug 13, 2024	BUY	$5.36 - $7.11 $116 Million - $154 Million	21,671,365 Added 12164.13%	21,849,523 $139 Million
Q1 2024 May 13, 2024	BUY	$5.24 - $6.34 $20,598 - $24,922	3,931 Added 2.26%	178,158 $1.08 Million
Q4 2023 Feb 09, 2024	BUY	$3.36 - $6.21 $355,518 - $657,073	105,809 Added 154.65%	174,227 $1.06 Million
Q3 2023 Nov 09, 2023	BUY	$2.76 - $4.59 $156,020 - $259,468	56,529 Added 475.47%	68,418 $288,000
Q2 2023 Aug 11, 2023	BUY	$1.33 - $3.1 $8,836 - $20,596	6,644 Added 126.67%	11,889 $36,000
Q1 2023 May 12, 2023	SELL	$1.27 - $2.7 $17,447 - $37,092	-13,738 Reduced 72.37%	5,245 $7,000
Q4 2022 Feb 08, 2023	SELL	$1.96 - $2.61 $14,880 - $19,815	-7,592 Reduced 28.57%	18,983 $37,000
Q3 2022 Nov 10, 2022	BUY	$2.02 - $3.62 $31,168 - $55,856	15,430 Added 138.45%	26,575 $54,000
Q2 2022 Aug 10, 2022	SELL	$3.01 - $4.46 $3,590 - $5,320	-1,193 Reduced 9.67%	11,145 $35,000
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $97,429 - $122,161	-24,982 Reduced 66.94%	12,338 $51,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $103,964 - $153,972	26,320 Added 239.27%	37,320 $178,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $39,833 - $52,124	-9,242 Reduced 45.66%	11,000 $59,000
Q2 2021 Aug 13, 2021	BUY	$5.12 - $6.82 $47,319 - $63,030	9,242 Added 84.02%	20,242 $103,000
Q1 2021 May 12, 2021	SELL	$4.74 - $7.38 $204,052 - $317,701	-43,049 Reduced 79.65%	11,000 $74,000
Q4 2020 Feb 11, 2021	BUY	$3.95 - $5.42 $46,554 - $63,880	11,786 Added 27.89%	54,049 $247,000
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $138,707 - $206,494	-39,183 Reduced 48.11%	42,263 $164,000
Q2 2020 Jul 31, 2020	BUY	$2.87 - $5.46 $198,334 - $377,318	69,106 Added 560.02%	81,446 $387,000
Q1 2020 May 01, 2020	BUY	$2.46 - $5.35 $16,826 - $36,594	6,840 Added 124.36%	12,340 $43,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $5,639 - $11,831	-2,128 Reduced 27.9%	5,500 $27,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $35,827 - $111,079	-15,645 Reduced 67.22%	7,628 $22,000
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $116,911 - $259,420	-18,154 Reduced 43.82%	23,273 $167,000
Q1 2019 May 14, 2019	SELL	$11.87 - $14.84 $401,099 - $501,458	-33,791 Reduced 44.92%	41,427 $586,000
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $331,451 - $544,148	25,321 Added 50.75%	75,218 $1.02 Million
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $112,011 - $165,764	-6,830 Reduced 12.04%	49,897 $1.11 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $791,341 - $1.15 Million	56,727 New	56,727 $931,000

Others Institutions Holding AMRX

# of Institutions

249

Shares Held

145M

Call Options Held

194K

Put Options Held

49.3K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.59B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account